Bacteria Work Shows Profit in Openness From Novozymes to Pepsi

It was an experiment with bacteria that emboldened Novozymes A/S into stepping up disclosures about its work to pressure groups. The openness paid off, and now the manufacturer is part of a growing club pushing transparency worldwide.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.